首页> 外文期刊>Archives of disease in childhood >P14?Reducing medication errors using prescribing nudges: intravenous aciclovir on paediatric intensive care
【24h】

P14?Reducing medication errors using prescribing nudges: intravenous aciclovir on paediatric intensive care

机译:P14?使用规定的言论减少药物误差:静脉注射Aciclovir对儿科重症监护

获取原文
       

摘要

Aim This Quality Improvement project is the second phase of a long term project to improve the quality of prescribing on the paediatric intensive care unit (PICU). Small adjustments are made to the electronic prescribing (EP) system, known as ‘nudges’, with the aim of improving the quality of prescribing in terms of error rate or user experience. 1 2 Intravenous aciclovir is prescribed to most patients admitted to the PICU with suspected meningitis/encephalitis. There is a complicated dosing schedule where the prescriber must decide whether to use body surface area (BSA) or weight to calculate the required dose. Underdosing risks subtherapeutic treatment of a viral encephalitis and overdosing risks acute kidney injury. Within our EP system, dosing by weight can be automated, but dosing by BSA cannot. A project in 2018 used a ‘nudge’ to alter the order of prescribing options in the drop down menu on the EP system. This reduced the error rate from 26% to 17% by reducing the likelihood of picking the wrong indication for acyclovir. 3 However, a re-audit in October to December 2018 found the error rate had crept back up to 32%. Prescribing on the EP system is a multi-step process. Prescribers had to pick ‘aciclovir’ to choose the weight based dose or ‘aciclovir injection 3 month-11 yr‘ to choose the BSA based dosing. When ‘aciclovir’ was picked, this removed the body surface area dosing option from the prescriber’s screen and led them in the direction of an incorrect dose. Method The intervention for this project was to amalgamate all weight and BSA dosing options for acyclovir within the EP system, and then order them by age so that the prescriber could see all options simultaneously. This change was designed and implemented by our electronic prescribing support pharmacist in April 2019. Pre and post change prescriptions were audited by pharmacy undergraduate students for accuracy using data downloaded from the EP system. Results The error rate post change was 8% (pre change 32%). The remaining errors reflect transcribing of an incorrect dose initiated outside of the PICU from a referring ward or hospital. Conclusion This project shows that small, ‘smart’ changes within EP configuration can improve the quality of prescribing.Future work involves working with the software company to incorporate the ability to automatically calculate the dose based on BSA, further reducing the need for manual calculations. This project would not have been possible without the skills and knowledge of our electronic prescribing support pharmacy team.
机译:旨在这个质量改进项目是长期项目的第二阶段,以提高儿科重症监护单位(PICU)的处方质量。对电子规定(EP)系统进行的小调整,称为“粗俗”,目的是提高错误率或用户体验方面的处方质量。 1 2静脉内Aciclovir患者患有涉及脑膜炎/脑炎的大多数患者患者。存在一个复杂的计量时间表,其中,处方者必须决定是否使用体表面积(BSA)或重量来计算所需的剂量。减少风险亚治疗病毒脑炎和过量风险急性肾损伤。在我们的EP系统中,通过重量计量可以自动化,但BSA的给药不能。 2018年的项目使用了“轻推”来改变EP系统下拉菜单中规定选项的顺序。通过减少挑选Acyclovir的错误指示的可能性,这将误差率从26%降低到17%。 3但是,2018年10月至2018年12月的重新审计发现错误率升高至32%。 EP系统上的处方是一个多步骤过程。处方必须选择“Aciclovir”以选择体重的剂量或'Aciclovir注入3个月-11yr'以选择基于BSA的剂量。当“Aciclovir”挑选时,这会从前方的屏幕上取下身体表面积给药选项,并在不正确剂量的方向上导致它们。方法对该项目的干预是合并在EP系统中的Acyclovir中的所有体重和BSA给药选项,然后按年龄命令,使处方能够同时查看所有选项。这一变化由我们的电子处方支持药剂师于2019年4月设计和实施。使用从EP系统下载的数据进行药房本科学生进行预先和后期更改处方。结果错误率后变化为8%(预先改变32%)。剩余的错误反映从参考病房或医院转录PICU外部的不正确剂量。结论该项目表明,EP配置中的小型“智能”变化可以提高规定的质量.Future工作涉及与软件公司合作,纳入自动计算基于BSA的剂量的能力,进一步降低了手动计算的需求。没有我们电子处方支持药房团队的技能和知识,此项目将无法实现。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号